Anti‐factor Xa (anti‐Xa) monitoring of unfractionated heparin (UFH) is associated with less time to achieve therapeutic anticoagulation compared to the activated partial thromboplastin time (aPTT). However, it is unknown whether clinical outcomes differ between these methods of monitoring. The aim ...
The anti–factor Xa assay is designed to measure plasma heparin (unfractionated heparin [UH] and low molecular weight heparin [LMWH]) levels and to monitor anticoagulant therapy. Therapeutic ranges of heparin are as follows: LMWH: 0.
精准监测之Anti-Xa 精准监测之Anti-Xa 抗Xa活性测定，可针对临床上广泛用于预防和治疗血栓性疾病的抗凝血药物—普通肝素和低分子肝素的药效进行监测，较传统的实验室监测方法APTT，抗Xa活性测定方法更为特异，检测结果稳定，可以更真实地体现病人体内的抗凝效果。本文参考相关国内外文献及临床指南/共识，对肝素监测的两...
The INNOVANCE®Anti-Xa assay1is an automated chromogenic assay for the quantitative determination of the activity of unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) as well as rivaroxaban, apixaban and edoxaban concentrations in citrated human plasma. The INNOVANCE Anti-Xa assay...
This study assessed the relationships between rivaroxaban-specific anti-factor Xa activity (AXA) and unfractionated heparin (UFH)-specific AXA and determined the cutoff level for UFH-specific AXA in critical situations for patients undergoing rivaroxaban therapy. Methods Thirty-eight blood samples were ...
Correlation between anti-Xa and occurrence of thrombosis and haemorrhage in post-surgical patients treated with either Logiparin(R) (LMWH) or unfractionated heparin. Thromb Res. 1992;65:641-50.Bara L, Leizorovicz A, Picolet H, Samama M. Correlation bet- ween anti-Xa and occurrence of ...
Background: Unfractionated heparin has been traditionally used for anticoagulation during hemodialysis (HD), but more recently low-molecular-weight heparin (LMWH) is being used as an alternative. Anti-Xa activity can be measured as a surrogate of LMWH efficacy. We present 52 patients treated with ...
Unfractionated heparin (UFH) has unstable pharmacokinetics and requires close monitoring. The activated partial thromboplastin time (aPTT) test has been used to monitor UFH therapy for decades in Korea, but its results can be affected by numerous variables. We established an aPTT heparin therapeutic ...
Safety and Effectiveness of an Anti-Xa-based Unfractionated Heparin Protocol for Impella Percutaneous Ventricular Assist Devices Results: Anti-Xa values were in therapeutic range 46% of the time while on support (interquartile range 16.6%-75%), with a median IV UFH dose of ... SE Berman,L ...
Low-molecular weight heparin (LMWH) is the product of enzymatic or chemical degradation of unfractionated heparin (UFH). It has been found to have better b... BKH Ip,AR Thomson,HT Moriarty - 《Pathology》 被引量: 31发表: 2001年 Anti-Xa stability of diluted dalteparin for pediatric use. ...